CEO Sheri Dodd was paid $3,466,916 in fiscal year 2025, ↑ up 40.0% from fiscal year 2024, the 20th percentile of its disclosed peer group (SEC filing 0001104659-26-034206 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
$3,466,916 ↑ Sheri Dodd total, FY2025 | 20th CEO pay percentile vs peers | 39:1 CEO-to-median pay ratio | 97.24% Say-on-pay support, latest vote |
Track this company's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year
Ask our research desk — $99, 24h, every figure cited to its filing.
TCMD's next annual pay disclosure, estimated March 22, 2027.est. Filing ↗
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Sheri Dodd | $675,000 | $0 | $2,019,978 | $0 | $737,438 | $0 | $34,500 | $3,466,916 |
| Chief Executive Officer | ||||||||
| Elaine Birkemeyer | 450,000 | 0 | 1,114,988 | 0 | 310,500 | 0 | 17,500 | 1,892,988 |
| Chief Financial Officer | ||||||||
| Kristie Burns | 400,000 | 0 | 509,970 | 0 | 230,000 | 0 | 17,500 | 1,157,470 |
| Senior Vice President, Marketing and Clinical Affairs | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Sheri Dodd | $3,466,916 | $2,476,841 | — | ↑ +990,075 |
| Elaine Birkemeyer | 1,892,988 | 1,397,878 | 1,353,259 | ↑ +495,110 |
| Kristie Burns | 1,157,470 | 1,009,460 | 986,998 | ↑ +148,010 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
You have just read TACTILE SYSTEMS TECHNOLOGY INC's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper TCMD reports.
We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.
Get the TACTILE SYSTEMS TECHNOLOGY INC Peer Teardown Report
$3,466,916 Sheri Dodd total, FY2025
$199
The free page is the headline. The teardown reads every company in the disclosed peer group on its own numbers.
Data as of October 8, 2026 · Source: 0001104659-26-034206 · Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
Reports for TCMD
Every report below is generated from the same filings as the free brief above, at the moment of purchase. What each one adds:
Order TCMD
Pick the report, add the email the receipt and the PDF go to, and pay by card on Stripe.
How we handle your data → Privacy
Each company listed discloses TCMD in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named TCMD in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
Get the TACTILE SYSTEMS TECHNOLOGY INC Executive Compensation Report
$1,500
One page per director: the seat, the committees and the fee table, read for one person at a time.
| Director | Role | FY2025 total |
|---|---|---|
| Andrea A. Pearson | Independent Director | — |
| B. Vindell Washington | Independent Director | $219,992 |
| Carmen B. Volkart | Independent Director | $232,492 |
| D. Brent Shafer | Independent Director | $222,492 |
| Daniel L. Reuvers | Former director (through FY2025) | $153,462 |
| Laura G. King | Independent Director | $219,992 |
| Raymond O. Huggenberger | Independent Director | $224,992 |
| Valerie L. Asbury | Independent Director | $224,992 |
| William W. Burke | Chair of the Board | $264,992 |
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| B. Vindell Washington | Director | 2026-05-06 | A | 6,521 | $0 | $0 | Common | Form 4 ↗ |
| William W. Burke | Director | 2026-05-06 | A | 6,521 | 0 | 0 | Common | Form 4 ↗ |
| Carmen B. Volkart | Director | 2026-05-06 | A | 6,521 | 0 | 0 | Common | Form 4 ↗ |
| D. Brent Shafer | Director | 2026-05-06 | A | 6,521 | 0 | 0 | Common | Form 4 ↗ |
| Laura G. King | Director | 2026-05-06 | A | 6,521 | 0 | 0 | Common | Form 4 ↗ |
| Valerie L. Asbury | Director | 2026-05-06 | A | 6,521 | 0 | 0 | Common | Form 4 ↗ |
| Raymond O. Huggenberger | Director | 2026-05-06 | A | 6,521 | 0 | 0 | Common | Form 4 ↗ |
| Andrea A. Pearson | Director | 2026-05-06 | A | 6,521 | 0 | 0 | Common | Form 4 ↗ |
| Elaine Birkemeyer | CHIEF FINANCIAL OFFICER | 2026-05-11 | D | 4,631 | 24 | 113,404 | Common | Form 4 ↗ |
| Sheri Louise Dodd | Director | 2026-08-10 | D | 10,978 | 29 | 323,243 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Elaine Birkemeyer | RSU | 2025-02-20 | — | — | 36,248 | — | $557,494 |
| Sheri Dodd | PSU | 2025-02-20 | 16,417 | 65,669 | — | 114,920 | 1,009,989 |
| Kristie Burns | RSU | 2025-02-20 | — | — | 16,579 | — | 254,985 |
| Sheri Dodd | RSU | 2025-02-20 | — | — | 65,669 | — | 1,009,989 |
| Kristie Burns | PSU | 2025-02-20 | 4,144 | 16,579 | — | 29,013 | 254,985 |
| Elaine Birkemeyer | PSU | 2025-02-20 | 9,062 | 36,248 | — | 63,434 | 557,494 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Elaine Birkemeyer | $557,494 | $557,494 | $0 | 50.0% |
| Sheri Dodd | 1,009,989 | 1,009,989 | 0 | 50.0% |
| Kristie Burns | 254,985 | 254,985 | 0 | 50.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Sheri Dodd | PSU | 43,779 | — | $1,269,601 |
| Sheri Dodd | RSU | 65,669 | — | 1,904,401 |
| Elaine Birkemeyer | PSU | 24,165 | — | 700,795 |
| Sheri Dodd | RSU | 20,108 | — | 583,132 |
| Kristie Burns | RSU | 16,579 | — | 480,791 |
| Elaine Birkemeyer | RSU | 15,575 | — | 451,675 |
| Kristie Burns | PSU | 11,053 | — | 320,527 |
| Kristie Burns | PSU | 4,324 | — | 125,396 |
| Elaine Birkemeyer | RSU | 9,691 | — | 281,039 |
| Elaine Birkemeyer | RSU | 36,248 | — | 1,051,192 |
| Sheri Dodd | RSU | 28,216 | — | 818,264 |
| Elaine Birkemeyer | RSU | 21,614 | — | 626,806 |
| Elaine Birkemeyer | PSU | 7,205 | — | 208,945 |
| Kristie Burns | RSU | 5,576 | — | 161,704 |
| Elaine Birkemeyer | RSU | 2,848 | — | 82,592 |
| Sheri Dodd | PSU | 21,035 | — | 610,015 |
| Kristie Burns | RSU | 4,131 | — | 119,799 |
| Sheri Dodd | RSU | 43,306 | — | 1,255,874 |
| Kristie Burns | RSU | 12,968 | — | 376,072 |
| Kristie Burns | RSU | 7,123 | — | 206,567 |
Our compensation programs are designed to: attract and retain individuals with superior ability and managerial experience; align executive officers incentives with our corporate strategies, business objectives and the long-term interests of our stockholders; and increase the incentive to achieve key strategic performance measures by linking incentive award opportunities to the achievement of performance objectives and by providing a portion of total compensation for executive officers in the form of ownership in the Company.
| CEO STI target (% of salary) | 95% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Aon Consulting, Inc. |
| Clawback policy | True |
| Anti-hedging | True |
| Anti-pledging | True |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-05-06 | 15,375,172 | 376,801 | 60,089 | 97.24% | Passed |
| 2025 | 2025-05-07 | 15,658,844 | 321,637 | 12,827 | 97.91% | Passed |
| 2024 | 2024-05-08 | 17,781,574 | 419,547 | 22,528 | 97.57% | Passed |
| 2023 | 2023-05-08 | 13,657,526 | 597,842 | 47,157 | 95.49% | Passed |
| 2022 | 2022-05-09 | 15,127,920 | 403,898 | 35,644 | 97.18% | Passed |
| 2021 | 2021-05-17 | 16,763,256 | 240,274 | 20,936 | 98.47% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-05-06 | 97.24%a |
| 2025 | 2025-05-07 | 97.91%b |
| 2024 | 2024-05-08 | 97.57%c |
a. Approved under the standard stated in the filing — “ Abstentions will have the same effect as votes cast AGAINST the proposal.”.
b. Approved under the standard stated in the filing — “ Abstentions will have the same effect as votes cast AGAINST the proposal.”.
c. Approved under the standard stated in the filing — “ Abstentions will have the same effect as votes cast AGAINST the proposal.”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | 39 : 1 |
|---|---|
| CEO total compensation | $3,466,916 |
| Median employee compensation | $88,317 |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| William W. BurkeIndependent · Board Chair | $110,000 | $154,992 | $0 | $0 | $0 | $264,992 |
| Carmen B. VolkartIndependent · Audit (Chair) · Compensation and Organization | 77,500 | 154,992 | 0 | 0 | 0 | 232,492 |
| Valerie L. AsburyIndependent · Audit · Nominating and Corporate Governance (Chair) | 70,000 | 154,992 | 0 | 0 | 0 | 224,992 |
| Raymond O. HuggenbergerIndependent · Compensation and Organization (Chair) · Compliance and Reimbursement | 70,000 | 154,992 | 0 | 0 | 0 | 224,992 |
| D. Brent ShaferIndependent · Audit · Compensation and Organization | 67,500 | 154,992 | 0 | 0 | 0 | 222,492 |
| Laura G. KingIndependent · Audit · Compliance and Reimbursement | 65,000 | 154,992 | 0 | 0 | 0 | 219,992 |
| B. Vindell WashingtonIndependent · Nominating and Corporate Governance · Compliance and Reimbursement (Chair) | 65,000 | 154,992 | 0 | 0 | 0 | 219,992 |
| Daniel L. ReuversNot independent · Not standing for re-election · Departed during FY | 153,462 | 0 | 0 | 0 | 0 | 153,462 |
| Andrea A. PearsonIndependent · Nominating and Corporate Governance · Compliance and Reimbursement · Newly elected | 0 | 0 | 0 | 0 | 0 | 0 |
| Sheri L. DoddEmployee director | 0 | 0 | 0 | — | 0 | 0 |
| Annual cash retainer | $50,000 |
|---|---|
| Annual equity retainer | $155,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 50,000 |
| Stock ownership guideline | 5x annual Board cash retainer ($250,000) |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $678,462 |
| Equity awards (grant-date value) | $1,084,944 |
| All other compensation | $0 |
| Total cost of the board | $1,763,406 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies TACTILE SYSTEMS TECHNOLOGY INC names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including TACTILE SYSTEMS TECHNOLOGY INC.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Glaukos Corporation | 2025 | Thomas Burns | $850,000 | $7,649,947 | $3,527,497 | $0 | $12,034,087 |
| 2 | Nevro Corp. | 2023 | Kevin Thornal | 515,625 | 10,080,173 | 0 | 402,750 | 11,453,548 |
| 3 | iRhythm Technologies, Inc. | 2025 | Quentin Blackford | 700,003 | 8,919,457 | 0 | 1,350,000 | 11,003,163 |
| 4 | AtriCure, Inc. | 2025 | Michael Carrel | 828,439 | 7,203,478 | 0 | 1,171,703 | 9,217,620 |
| 5 | Axogen, Inc. | 2025 | Michael Dale | 775,865 | 7,342,895 | 0 | 906,133 | 9,047,454 |
| 6 | STAAR Surgical Company | 2025 | Stephen Farrell | 580,000 | 6,836,000 | 0 | 0 | 7,522,385 |
| 7 | SI-BONE, Inc. | 2025 | Laura Francis | 685,000 | 6,038,710 | 0 | 729,525 | 7,453,235 |
| 8 | Cutera, Inc. | 2023 | Taylor Harris | 271,023 | 2,747,682 | 4,250,008 | 0 | 7,279,813 |
| 9 | Artivion, Inc. | 2025 | J. Patrick Mackin | 835,145 | 5,006,990 | 0 | 991,368 | 6,883,108 |
| 10 | AngioDynamics, Inc. | 2026 | James Clemmer | 828,171 | 3,689,866 | 0 | 1,502,491 | 6,060,145 |
| 11 | LeMaitre Vascular, Inc. | 2025 | George LeMaitre | 806,347 | 1,050,000 | 1,050,000 | 680,015 | 3,780,990 |
| 12 | Surmodics, Inc. | 2024 | Gary Maharaj | 647,481 | 940,000 | 1,410,000 | 654,215 | 3,665,496 |
| 13 | TACTILE SYSTEMS TECHNOLOGY INC | 2025 | Sheri Dodd | 675,000 | 2,019,978 | 0 | 737,438 | 3,466,916 |
| 14 | Outset Medical, Inc. | 2025 | Leslie Trigg | 755,166 | 2,197,882 | 0 | 294,515 | 3,255,510 |
| 15 | Inogen, Inc. | 2025 | Kevin R.M. Smith | 711,077 | 1,874,550 | 0 | 0 | 2,613,804 |
| 16 | Zynex, Inc. | 2024 | Thomas Sandgaard | 700,000 | 112,458 | 0 | 170,625 | 991,810 |
| — | Axonics, Inc. | — | — | — | — | — | — | not in coverage universe |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| TACTILE SYSTEMS TECHNOLOGY INC | 115% | PSU 50 · RSU 50 | No | Aon Consulting, Inc. |
| AngioDynamics, Inc. | 180% | PSU 50 · RSU 50 | No | Meridian Compensation Partners, LLC |
| Artivion, Inc. | 118.7% | PSU 50 · RSU 50 | No | Willis Towers Watson |
| AtriCure, Inc. | 141% | PSU 70 · RSU 30 | No | Korn Ferry |
| Axogen, Inc. | 116.79% | PSU 50 · RSU 50 | No | Aon |
| Axonics, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Cutera, Inc. | not disclosed | not disclosed | No | Compensia |
| Glaukos Corporation | 177.5% | RSU 50 · PRSU 50 | No | Frederic W. Cook & Co., Inc. |
| Inogen, Inc. | 60% | RSU 50 · PRSU 50 | No | Aon |
| iRhythm Technologies, Inc. | 173% | RSU 50 · PSU 50 | Yes — Relative TSR | Aon and Mercer |
| LeMaitre Vascular, Inc. | not disclosed | Option 50 · RSU 25 · PSU 25 | No | not disclosed |
| Nevro Corp. | 53.7% | not disclosed | No | Aon |
| Outset Medical, Inc. | 39% | PSU 50 · RSU 50 | Yes — Relative TSR compared to Russell 2000 Medical Device Index | Pearl Meyer |
| SI-BONE, Inc. | 106.5% | RSU 50 · PSU 50 | Yes — Relative TSR | Compensia, Inc. |
| STAAR Surgical Company | 135% | RSU 50 · PSU 50 | No | Semler Brossy |
| Surmodics, Inc. | 126.3% | Option 60 · Restricted Shares 40 | not disclosed | Pay Governance LLC |
| Zynex, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Sheri Dodd | DEF 14A | 2026-03-25 | 0001104659-26-034206 | Section “2025 Summary Compensation Table”. As printed: 3,466,916. Filing ↗machine: r3 · c12 · span 865797–865806 |
| 2 | Section 01, Elaine Birkemeyer | DEF 14A | 2026-03-25 | 0001104659-26-034206 | Section “2025 Summary Compensation Table”. As printed: 1,892,988. Filing ↗machine: r6 · c12 · span 875949–875958 |
| 3 | Section 01, Kristie Burns | DEF 14A | 2026-03-25 | 0001104659-26-034206 | Section “2025 Summary Compensation Table”. As printed: 1,157,470. Filing ↗machine: r9 · c12 · span 886353–886362 |
| 4 | Section 03, Elaine Birkemeyer RSU | DEF 14A | 2026-03-25 | 0001104659-26-034206 | Section “Grants of Plan-Based Awards in 2025” · grants of plan-based awards table. Filing ↗machine: span 925825–925832 |
| 5 | Section 03, Sheri Dodd PSU | DEF 14A | 2026-03-25 | 0001104659-26-034206 | Section “Grants of Plan-Based Awards in 2025” · grants of plan-based awards table. Filing ↗machine: span 921757–921766 |
| 6 | Section 03, Kristie Burns RSU | DEF 14A | 2026-03-25 | 0001104659-26-034206 | Section “Grants of Plan-Based Awards in 2025” · grants of plan-based awards table. Filing ↗machine: span 930998–931005 |
| 7 | Section 03, Sheri Dodd RSU | DEF 14A | 2026-03-25 | 0001104659-26-034206 | Section “Grants of Plan-Based Awards in 2025” · grants of plan-based awards table. Filing ↗machine: span 920737–920746 |
| 8 | Section 03, Kristie Burns PSU | DEF 14A | 2026-03-25 | 0001104659-26-034206 | Section “Grants of Plan-Based Awards in 2025” · grants of plan-based awards table. Filing ↗machine: span 932078–932085 |
| 9 | Section 03, Elaine Birkemeyer PSU | DEF 14A | 2026-03-25 | 0001104659-26-034206 | Section “Grants of Plan-Based Awards in 2025” · grants of plan-based awards table. Filing ↗machine: span 926845–926852 |
| 10 | Section 07, pay ratio | DEF 14A | 2026-03-25 | 0001104659-26-034206 | Section “CEO Pay Ratio”. As printed: 39 : 1. Filing ↗machine: t171 · span 1281808–1281877 |
| 11 | Section 08, William W. Burke | DEF 14A | 2026-03-25 | 0001104659-26-034206 | Section “Director Compensation”. As printed: 264,992. Filing ↗machine: t54 · r3 · c6 · span 450779–450941 |
| 12 | Section 08, Carmen B. Volkart | DEF 14A | 2026-03-25 | 0001104659-26-034206 | Section “Director Compensation”. As printed: 232,492. Filing ↗machine: t54 · r7 · c6 · span 457969–458131 |
| 13 | Section 08, Valerie L. Asbury | DEF 14A | 2026-03-25 | 0001104659-26-034206 | Section “Director Compensation”. As printed: 224,992. Filing ↗machine: t54 · r4 · c6 · span 452642–452804 |
| 14 | Section 08, Raymond O. Huggenberger | DEF 14A | 2026-03-25 | 0001104659-26-034206 | Section “Director Compensation”. As printed: 224,992. Filing ↗machine: t54 · r5 · c6 · span 454378–454540 |
| 15 | Section 08, D. Brent Shafer | DEF 14A | 2026-03-25 | 0001104659-26-034206 | Section “Director Compensation”. As printed: 222,492. Filing ↗machine: t54 · r6 · c6 · span 456239–456401 |
| 16 | Section 08, Laura G. King | DEF 14A | 2026-03-25 | 0001104659-26-034206 | Section “Director Compensation”. As printed: 219,992. Filing ↗machine: t54 · r8 · c6 · span 459825–459987 |
| 17 | Section 08, B. Vindell Washington | DEF 14A | 2026-03-25 | 0001104659-26-034206 | Section “Director Compensation”. As printed: 219,992. Filing ↗machine: t54 · r9 · c6 · span 461509–461671 |
| 18 | Section 08, Daniel L. Reuvers | DEF 14A | 2026-03-25 | 0001104659-26-034206 | Section “Director Compensation”. As printed: 153,462. Filing ↗machine: t54 · r10 · c6 · span 462425–462587 |
| 19 | Section 08, Andrea A. Pearson | DEF 14A | 2026-03-25 | 0001104659-26-034206 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 20 | Section 08, Sheri L. Dodd | DEF 14A | 2026-03-25 | 0001104659-26-034206 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 21 | Section 02, B. Vindell Washington 2026-05-06 | Form 4 | 2026-05-08 | 0001994641-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 22 | Section 02, William W. Burke 2026-05-06 | Form 4 | 2026-05-08 | 0001200612-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 23 | Section 02, Carmen B. Volkart 2026-05-06 | Form 4 | 2026-05-08 | 0001282953-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 24 | Section 02, D. Brent Shafer 2026-05-06 | Form 4 | 2026-05-08 | 0001728374-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 25 | Section 02, Laura G. King 2026-05-06 | Form 4 | 2026-05-08 | 0002049487-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 26 | Section 02, Valerie L. Asbury 2026-05-06 | Form 4 | 2026-05-08 | 0001904264-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 27 | Section 02, Raymond O. Huggenberger 2026-05-06 | Form 4 | 2026-05-08 | 0001596078-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 28 | Section 02, Andrea A. Pearson 2026-05-06 | Form 4 | 2026-05-08 | 0001478345-26-000010 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 29 | Section 02, Elaine Birkemeyer 2026-05-11 | Form 4 | 2026-05-13 | 0001968559-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 30 | Section 02, Sheri Louise Dodd 2026-08-10 | Form 4 | 2026-08-12 | 0001837111-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 31 | Section 06, 2026 vote | Form 8-K | 2026-05-07 | 0001104659-26-057271 | Item 5.07 · say-on-pay result. As reported: 97.24% (votes for as printed: 15,375,172). Filing ↗ |
| 32 | Section 06, 2025 vote | Form 8-K | 2025-05-09 | 0001104659-25-046813 | Item 5.07 · say-on-pay result. As reported: 97.91% (votes for as printed: 15,658,844). Filing ↗ |
| 33 | Section 06, 2024 vote | Form 8-K | 2024-05-09 | 0001104659-24-059336 | Item 5.07 · say-on-pay result. As reported: 97.57% (votes for as printed: 17,781,574). Filing ↗ |
| 34 | Section 01 trend, Δ column (computed) | Computed | — | — | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 35 | Section 03b vehicle mix (computed) | Computed | — | — | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 36 | Section 09b board cost (computed) | Computed | — | — | Cash 678,462 + equity 1,084,944 + all other 0 = 1,763,406, summed across the director compensation table rows.machine: formula: Σ = 1,763,406 |
| 37 | Glaukos Corporation, Section 10b CEO total | DEF 14A | 2026-04-16 | 0001193125-26-157829 | CEO total compensation as printed in Glaukos Corporation's own proxy. As printed: 12,034,087. Filing ↗machine: r6 · c38 · span 1876942–1876952 |
| 38 | Nevro Corp., Section 10b CEO total | DEF 14A | 2024-04-12 | 0000950170-24-044100 | CEO total compensation as printed in Nevro Corp.'s own proxy. As printed: 11,453,548. Filing ↗machine: r2 · c16 · span 631983–631993 |
| 39 | iRhythm Technologies, Inc., Section 10b CEO total | DEF 14A | 2026-04-17 | 0001388658-26-000030 | CEO total compensation as printed in iRhythm Technologies, Inc.'s own proxy. As printed: 11,003,163. Filing ↗machine: r2 · c21 · span 1123498–1123508 |
| 40 | AtriCure, Inc., Section 10b CEO total | DEF 14A | 2026-04-06 | 0001323885-26-000010 | CEO total compensation as printed in AtriCure, Inc.'s own proxy. As printed: 9,217,620. Filing ↗machine: span 743364–743373 |
| 41 | Axogen, Inc., Section 10b CEO total | DEF 14A | 2026-04-29 | 0000805928-26-000057 | CEO total compensation as printed in Axogen, Inc.'s own proxy. As printed: 9,047,454. Filing ↗machine: r2 · c45 · span 557309–557318 |
| 42 | STAAR Surgical Company, Section 10b CEO total | DEF 14A | 2026-05-04 | 0000718937-26-000015 | CEO total compensation as printed in STAAR Surgical Company's own proxy. As printed: 7,522,385. Filing ↗machine: r3 · c16 · span 1045477–1045486 |
| 43 | SI-BONE, Inc., Section 10b CEO total | DEF 14A | 2026-04-21 | 0001459839-26-000049 | CEO total compensation as printed in SI-BONE, Inc.'s own proxy. As printed: 7,453,235. Filing ↗machine: r3 · c18 · span 626969–626978 |
| 44 | Cutera, Inc., Section 10b CEO total | DEF 14A | 2024-06-17 | 0001628280-24-028528 | CEO total compensation as printed in Cutera, Inc.'s own proxy. As printed: 7,279,813. Filing ↗machine: r4 · c46 · span 1221355–1221364 |
| 45 | Artivion, Inc., Section 10b CEO total | DEF 14A | 2026-04-01 | 0001999371-26-007510 | CEO total compensation as printed in Artivion, Inc.'s own proxy. As printed: 6,883,108. Filing ↗machine: r3 · c9 · span 741873–741882 |
| 46 | AngioDynamics, Inc., Section 10b CEO total | DEF 14A | 2026-10-08 | 0001140361-26-039022 | CEO total compensation as printed in AngioDynamics, Inc.'s own proxy. As printed: 6,060,145. Filing ↗machine: r2 · c27 · span 739870–739879 |
| 47 | LeMaitre Vascular, Inc., Section 10b CEO total | DEF 14A | 2026-04-14 | 0001193125-26-153877 | CEO total compensation as printed in LeMaitre Vascular, Inc.'s own proxy. As printed: 3,780,990. Filing ↗machine: r3 · c18 · span 564038–564047 |
| 48 | Surmodics, Inc., Section 10b CEO total | DEF 14A | 2024-12-19 | 0000950170-24-138240 | CEO total compensation as printed in Surmodics, Inc.'s own proxy. As printed: 3,665,496. Filing ↗machine: r3 · c25 · span 1568790–1568799 |
| 49 | TACTILE SYSTEMS TECHNOLOGY INC (subject), Section 10b CEO total | DEF 14A | 2026-03-25 | 0001104659-26-034206 | CEO total compensation as printed in TACTILE SYSTEMS TECHNOLOGY INC's own proxy. As printed: 3,466,916. Filing ↗machine: r3 · c12 · span 865797–865806 |
| 50 | Outset Medical, Inc., Section 10b CEO total | DEF 14A | 2026-04-24 | 0001193125-26-177150 | CEO total compensation as printed in Outset Medical, Inc.'s own proxy. As printed: 3,255,510. Filing ↗machine: r2 · c30 · span 1343364–1343373 |
| 51 | Inogen, Inc., Section 10b CEO total | DEF 14A | 2026-04-28 | 0001294133-26-000009 | CEO total compensation as printed in Inogen, Inc.'s own proxy. As printed: 2,613,804. Filing ↗machine: span 1140571–1140580 |
| 52 | Zynex, Inc., Section 10b CEO total | DEF 14A | 2025-03-28 | 0001558370-25-004019 | CEO total compensation as printed in Zynex, Inc.'s own proxy. As printed: 991,810. Filing ↗ |
| 53 | Section 10a, Artivion, Inc. reciprocity | DEF 14A | — | 0001999371-26-007510 | Artivion, Inc. names TACTILE SYSTEMS TECHNOLOGY INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 54 | Section 10a, LeMaitre Vascular, Inc. reciprocity | DEF 14A | — | 0001437749-23-010217 | LeMaitre Vascular, Inc. names TACTILE SYSTEMS TECHNOLOGY INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 55 | Section 10a, AngioDynamics, Inc. reciprocity | DEF 14A | — | 0001140361-26-039022 | AngioDynamics, Inc.'s most recent proxy was read; its disclosed peer group does not include TACTILE SYSTEMS TECHNOLOGY INC. Filing ↗ |
| 56 | Section 10a, AtriCure, Inc. reciprocity | DEF 14A | — | 0001323885-26-000010 | AtriCure, Inc. names TACTILE SYSTEMS TECHNOLOGY INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 57 | Section 10a, SI-BONE, Inc. reciprocity | DEF 14A | — | 0001459839-26-000049 | SI-BONE, Inc. names TACTILE SYSTEMS TECHNOLOGY INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 58 | Section 10a, Cutera, Inc. reciprocity | DEF 14A | — | 0001628280-24-028528 | Cutera, Inc. names TACTILE SYSTEMS TECHNOLOGY INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 59 | Section 10a, Outset Medical, Inc. reciprocity | DEF 14A | — | 0001193125-26-177150 | Outset Medical, Inc. names TACTILE SYSTEMS TECHNOLOGY INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 60 | Section 10a, iRhythm Technologies, Inc. reciprocity | DEF 14A | — | 0001388658-26-000030 | iRhythm Technologies, Inc. names TACTILE SYSTEMS TECHNOLOGY INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 61 | Section 10a, STAAR Surgical Company reciprocity | DEF 14A | — | 0000718937-26-000015 | STAAR Surgical Company's most recent proxy was read; its disclosed peer group does not include TACTILE SYSTEMS TECHNOLOGY INC. Filing ↗ |
| 62 | Section 10a, Glaukos Corporation reciprocity | DEF 14A | — | 0001193125-26-157829 | Glaukos Corporation's most recent proxy was read; its disclosed peer group does not include TACTILE SYSTEMS TECHNOLOGY INC. Filing ↗ |
| 63 | Section 10a, Inogen, Inc. reciprocity | DEF 14A | — | 0001294133-26-000009 | Inogen, Inc. names TACTILE SYSTEMS TECHNOLOGY INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 64 | Section 10a, Axogen, Inc. reciprocity | DEF 14A | — | 0000805928-26-000057 | Axogen, Inc. names TACTILE SYSTEMS TECHNOLOGY INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 65 | Section 10a, Surmodics, Inc. reciprocity | DEF 14A | — | 0000950170-24-138240 | Surmodics, Inc. names TACTILE SYSTEMS TECHNOLOGY INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 66 | Section 10a, Nevro Corp. reciprocity | DEF 14A | — | 0000950170-24-044100 | Nevro Corp.'s most recent proxy was read; its disclosed peer group does not include TACTILE SYSTEMS TECHNOLOGY INC. Filing ↗ |
| 67 | Section 10a, Zynex, Inc. reciprocity | DEF 14A | — | 0001558370-25-004019 | Zynex, Inc. names TACTILE SYSTEMS TECHNOLOGY INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.
You'll confirm on The Pay Desk's sign-up page.
Get the TACTILE SYSTEMS TECHNOLOGY INC Executive Compensation Report
$1,500